2026 NPPES data Advanced Heart Failure and Transplant Cardiology Physician NPI 1174518989 MD
Verify on CMS →

Mark Tallman, MD

Advanced Heart Failure and Transplant Cardiology Physician in Brighton, Massachusetts.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 566 in Advanced Heart Failure and Transplant Cardiology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
190
Medicare Part D claims · 45 beneficiaries · Advanced Heart Failure and Transplant Cardiology Physician avg: 2K
Generic prescribing
68%
generic claims · 32% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.3K
12 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Mark Tallman, MD filed 190 Medicare Part D claims in 2024 as an Advanced Heart Failure and Transplant Cardiology Physician in Brighton, Massachusetts, prescribing 68% generic.

190
Part D claims, 2024
68%
generic prescribing
Likely
board-certified (heuristic)
≥34th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Mark Tallman, MD

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1174518989), first enumerated 09/19/2005.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 190 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • Reported

    Industry payment transparency

    $1.3K in reported industry payments (12 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • State context

    State board disciplinary context

    Massachusetts statewide board action statistics are published annually — these figures describe aggregate state activity, not Mark Tallman, MD's individual license status. Verify directly with the state medical board.

    Source: BORIM annual report 2023

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1174518989 · Advanced Heart Failure and Transplant Cardiology Physician

NPI-10 · ENUM-LEGACY · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1174518989
  • ENUM-LEGACY 2005
  • TAX-NARROW 566
  • RX-LIGHT 190
  • BOOK-THIN 26 in Massachusetts
  • PHOTO-ENUM Gregory Egnaczyk · 2005

Mark Tallman, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

190 ≥ 34th percentile 34% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). This entry sits in this band. 200–400: 188,835 prescribers (13%). Above this entry. 400–600: 95,866 prescribers (7%). Above this entry. 600–800: 60,107 prescribers (4%). Above this entry. 800–1,000: 43,043 prescribers (3%). Above this entry. 1,000–1,200: 33,612 prescribers (2%). Above this entry. 1,200–1,400: 27,889 prescribers (2%). Above this entry. 1,400–1,600: 23,183 prescribers (2%). Above this entry. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board certification likely (heuristic, not verified)

Mark Tallman, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Mark Tallman, MD?

Quality data not reported

NPI registry status

Active

Issued 09/19/2005

NPI 1174518989

Primary specialty

Advanced Heart Failure and Transplant Cardiology Physician

Niche

566 US NPIs in this specialty

Medicare Part D claims

190 90% vs specialty avg

2024 prescription claims

Specialty avg: 1,916

Specialty distribution in Massachusetts

How Advanced Heart Failure and Transplant Cardiology Physician compares to other specialties among Massachusetts providers

Massachusetts providers
Mental Health Counselor8.3%Clinical Social Worker7.7%Student in an Organized Heal…6.2%Behavior Technician5.3%Counselor4.3%Internal Medicine Physician3.6%Advanced Heart Failure and T…0%
Largest specialties in Massachusetts (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Advanced Heart Failure and Transplant Cardiology Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

736 CAMBRIDGE ST FL 2
Brighton, MA 02135

Provider Details

NPI 1174518989
Specialty Advanced Heart Failure and Transplant Cardiology Physician
Credentials MD
Gender Male
NPI Issued 09/19/2005

Hospital and facility affiliations

Facilities where Mark Tallman, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Albany Medical College
Albany, NY
Bmc Affiliated Physicians, Inc.
Brighton, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mark Tallman, MD. Source: openpaymentsdata.cms.gov.

Total received

$1.3K

Largest payer

Abbott Laboratories

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Massachusetts BORIM 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 - they are NOT specific to Mark Tallman, MD. To verify Mark Tallman, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Mark Tallman, MD - brand share 32.0%
Advanced Heart Failure and Transplant Cardiology Physician average

32% brand-name claims vs 68% generic, on 190 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

190
Total Claims
$51K
Total Drug Cost
45
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
352
Total Day Supply
10,310
Brand vs Generic
32% brand / 68% generic
Brand Drug Cost
$49K
Generic Drug Cost
$2K

Patient Demographics

Average Patient Age
69.6 years
Avg HCC Risk Score
1.83
Gender Split
47% female / 53% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Mark Tallman, MD prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Entresto
Sacubitril/Valsartan
34
Atorvastatin Calcium
20
Losartan Potassium
13
Spironolactone
13
Farxiga
Dapagliflozin Propanediol
12
Metoprolol Succinate
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Advanced Heart Failure and Transplant Cardiology Physician Overview

How Mark Tallman, MD fits within the Advanced Heart Failure and Transplant Cardiology Physician landscape nationally.

566
Advanced Heart Failure and Transplant Cardiology Physician Providers in US
48
States with Advanced Heart Failure and Transplant Cardiology Physician
1,916
Avg Claims per Provider

Mark Tallman, MD's 190 claims are below the specialty average of 1,916.

Nationwide Advanced Heart Failure and Transplant Cardiology Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Tallman, both outside Massachusetts so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2005)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Advanced Heart Failure and Transplant Cardiology Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as Tallman.

One of 26 Advanced Heart Failure and Transplant Cardiology Physician providers enrolled in Massachusetts, 5 are shown here.

Compare Advanced Heart Failure and Transplant Cardiology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Mark Tallman, MD's specialty?
Mark Tallman, MD specializes in Advanced Heart Failure and Transplant Cardiology Physician and practices in Brighton, Massachusetts. Credentials: MD.
How much does Mark Tallman, MD prescribe under Medicare Part D?
In 2024, Mark Tallman, MD wrote 190 Medicare Part D claims totaling $51K in drug costs for 45 beneficiaries.
Where is Mark Tallman, MD located?
Mark Tallman, MD is located at 736 CAMBRIDGE ST FL 2, Brighton, MA, 02135. Phone: (617) 789-2344.
What is Mark Tallman, MD's NPI number?
Mark Tallman, MD's National Provider Identifier (NPI) is 1174518989, issued on 09/19/2005.
Does Mark Tallman, MD prescribe more brand-name or generic drugs?
Mark Tallman, MD's prescribing is 32% brand-name and 68% generic drugs by claim count, with $49K in brand drug costs.
How many Advanced Heart Failure and Transplant Cardiology Physician providers are there in the US?
There are 566 Advanced Heart Failure and Transplant Cardiology Physician providers across 48 states in the US. The average Advanced Heart Failure and Transplant Cardiology Physician provider writes 1,916 Medicare Part D claims per year.
What drugs does Mark Tallman, MD prescribe most often?
Based on 2024 Medicare Part D data, Mark Tallman, MD's most frequently prescribed drugs include Entresto, Atorvastatin Calcium, Losartan Potassium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mark Tallman, MD accept Medicare?
Mark Tallman, MD appears in CMS Medicare data with 190 Part D claims and 45 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mark Tallman, MD's credentials?
Mark Tallman, MD's NPI is 1174518989 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.